Edelmann establishes Edelmann Leaflet Solutions

Published: 10-Oct-2011
Packaging Finance

New firm is a merger of two of its operations in Germany

The Edelmann Group, a German folding cartons and leaflet specialist, is bundling its activities in the leaflets business into a new company called Edelmann Leaflet Solutions.

The newly founded company will merge two of the Group’s operations in Germany – Lindauer Druckerei Eschbaumer in Lindau and Wepack in Leverkusen.

The Heidenheim-based Edelmann Group extended its leaflets business in June by installing up-to-date folding machines in its facilities and with an overall annual capacity of 1.5 billion units, it is now one Germany’s largest leaflet manufacturers.

The firm says establishing Edelmann Leaflet Solutions will allow orders to be managed outside the individual facilities in Lindau and Leverkusen. This means that capacities can be increased at short notice and the duration of projects shortened while increasing flexibility.

In total Edelmann operates 12 sites serving the healthcare and beauty sectors: in Germany (Carl Edelmann, Artur Theis, Braun Pharmadruck, Lindauer Druckerei Eschbaumer, Wesche and Wepack), France (Edelmann France), Poland (Edelmann Poland), Hungary (Zalai Nyomda), Mexico (Edelmann Mexico) and China (Edelmann Beijing) and employs around 1,500 people.

In 2010, the Group generated revenue of €188m. Worldwide it produced 4.2 billion items of folding cartons and leaflets.

See more

You may also like

Packaging

The future of the package insert: the on-pack booklet-label

Read more
Novel solution developed by Schreiner MediPharm and Edelmann

Trending Articles

  1. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals
  2. Orphan drug sales to exceed $400bn by 2032, Evaluate report finds Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global prescription drug sales within a decade
  3. Viatris to cut 10% of its global workforce after Indian plant fire Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan
  4. Lonza completes transformation to pure-play CDMO with agreement to divest Capsules & Health Ingredients Sale of CHI business to Lone Star funds marks final step in Lonza’s strategic shift to a focused CDMO model
  5. CordenPharma Colorado expands peptide development capacity with lease of new lab Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Packaging

The future of the package insert: the on-pack booklet-label

Novel solution developed by Schreiner MediPharm and Edelmann
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Packaging firms develop smarter options

While serialisation is top of most agendas, the development of Cloud-based services and smart phone solutions also offer new marketing opportunities. Susan Birks reports
Packaging

Edelmann wins Pharmapack Award for vial packaging

Third award won by folding carton concept
Packaging

Edelmann leads development of standard for tamper-evident closures

European working group will publish initial draft this year
Packaging

Edelmann increases label production capacity

Invests in folding machines at three plants
Manufacturing

Schütz to build automated IBC production facility at BASF's Ludwigshafen headquarters

Packaging specialist Schütz has signed an agreement with BASF to construct a highly automated intermediate bulk container manufacturing and storage facility directly adjacent to the chemical giant's main plant in Ludwigshafen, enabling round-the-clock just-in-time delivery
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities

The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
Subscribe now